Table 2.
Indications for prescribing antimicrobial drugs (ATCa level 5) and the five most common antibiotics used
| Indication for antibiotic use | Top 5 antibiotic use among paediatric inpatients | ||||
|---|---|---|---|---|---|
| 1st | 2nd | 3rd | 4th | 5th | |
| All indications (n = 831) | Ceftriaxone (n = 124, 14.9%) | Gentamicin(n = 114, 13.7%) | Cefuroxime (n = 103, 12.4%) | Cloxacillin (n = 83, 9.9%) | Metronidazole (n = 82, 9.8%) |
| Community acquired infections (n = 508) | Ceftriaxone (n = 97, 19.1%) | Gentamicin (n = 85,16.7%) | Cefuroxime (n = 73, 14.4%) | Cloxacillin (n = 48, 9.4%) | Metronidazole (n = 47, 9.3%) |
| Hosptal acquired infections (n = 86) | Cloxacillin (n = 12, 14.0%) | Gentamicin (n = 12, 14.0%) | Cefuroxime (n = 8, 9.3%) | Ciprofloxacin(n = 7, 8.1%) | Amikacin (n = 6, 7.0%) |
| Ampicillin | |||||
| Ceftriaxone | |||||
| Meropenem | |||||
| Medical prophylaxis (n = 126) |
Ampicillin (n = 17, 13.5%) | Gentamicin (n = 1, 13.3%) | Cefotaxime (n = 16, 12.7%) | Amikacin (n = 14, 11.1%) | Crystal penicillin (n = 13, 10.3%) |
| Cloxacillin | |||||
| Surgical prophylaxis (n = 71) |
Metronidazole (n = 20, 28.2%) | Amoxicillin-clavulanic acid (n = 15, 21.1%) | Cefuroxime (n = 13, 18.3%) | Ceftriaxone (n = 7,9.9%) | Ampicillin (n = 4, 5.6%) |
| Ciprofloxacin | |||||
| Unknown (n = 40) |
Ceftriaxone (n = 8, 20.0%) | Amox-clavulanic acid (n = 4, 10.0%) | Metronidazole (n = 3, 7.5%) | Amikacin (n = 2, 5.0%) | Erythromycin (n = 1, 2.5%) |
| Ciprofloxacin | Cefuroxime | Azithromycin | |||
| Clindamycin | Crystal penicillin | Co-trimoxazole | |||
| Ampicillin | Amoxicillin | ||||
| Cloxacillin | |||||
| Gentamicin | |||||
aATC Anatomical Therapeutic Chemical Classification System